Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats

Robin E. Buckingham, John C. Clapham, C. D. N. Toseland et al.|Diabetes|1998

Cited by 205